0
Point/Counterpoint Editorials |

Counterpoint: Should Storefront Clinics Provide Case Finding and Chronic Care for COPD? NoStorefront Clinics for COPD? No

Bartolome R. Celli, MD, FCCP
Author and Funding Information

From the Pulmonary and Critical Care Medicine Division, Brigham and Women’s Hospital; and Department of Medicine, Harvard Medical School.

Correspondence to: Bartolome R. Celli, MD, FCCP, Pulmonary and Critical Care Medicine Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115; e-mail: bcelli@partners.org


Financial/nonfinancial disclosures: The author has reported to CHEST the following conflicts of interest: Dr Celli has participated in advisory boards for GlaxoSmithKline; Boehringer Ingelheim GmbH; Almirall, S.A.; AstraZeneca; Aeris; Deep Breeze Ltd; Takeda Pharmaceutical Company Limited; and Novartis Corp. The Pulmonary Division where Dr Celli is employed has received funds for research studies from GlaxoSmithKline; Boehringer Ingelheim GmbH; Forrest Medical, LLC; AstraZeneca; and Aeris. Dr Celli and his family do not have shares or interest in any company, and Dr Celli has not received tobacco money or stocks in any tobacco-related companies.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2014;145(6):1193-1194. doi:10.1378/chest.13-2862
Text Size: A A A
Published online

Extract

COPD is the cause of > 130,000 deaths in the United States alone, which is almost as many deaths as from lung cancer. Recent evidence indicates that although mortality from lung cancer is decreasing, that of COPD continues to increase.1 From this stark statistic, it is evident that we need to improve the early diagnosis of COPD and appropriately treat patients accordingly.2 It is attractive to believe that storefront clinics (SFCs) could serve as first-line resources to implement programs for detecting COPD; however, whatever evidence exists about the potential for diagnosis at an SFC, the issue of initiating and maintaining treatment at that level of care is nonexistent. Actually, I argue that management of patients based on this paradigm may be not only inappropriate but also dangerous. SFCs have sprouted in many places, and unfortunately, most states do not regulate the industry, a national registry does not exist, and the guidelines about what comprises the pulmonary care that can be provided at those sites is imaginary.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543